Storey RF - Search Results

1

Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study.

Parker WAE, Eriksson N, Becker RC, Voora D, Åkerblom A, Himmelmann A, James SK, Wallentin L, Storey RF; PLATO Investigators. Parker WAE, et al. Among authors: storey rf. Platelets. 2019;30(5):579-588. doi: 10.1080/09537104.2018.1478404. Epub 2018 May 31. Platelets. 2019. PMID: 29851527

2

The P2Y12 receptor as a therapeutic target in cardiovascular disease.

Storey RF. Storey RF. Platelets. 2001 Jun;12(4):197-209. doi: 10.1080/09537100120058739. Platelets. 2001. PMID: 11454254 Review.

3

Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease.

Storey RF, Wilcox RG, Heptinstall S. Storey RF, et al. Platelets. 2002 Nov;13(7):407-13. doi: 10.1080/0953710021000024402. Platelets. 2002. PMID: 12487788 Clinical Trial.

4

Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention.

Smith SM, Judge HM, Peters G, Storey RF. Smith SM, et al. Among authors: storey rf. Platelets. 2004 Dec;15(8):465-74. doi: 10.1080/0953710412331272532. Platelets. 2004. PMID: 15763887

5

Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes.

Behan MW, Fox SC, Heptinstall S, Storey RF. Behan MW, et al. Among authors: storey rf. Platelets. 2005 Mar;16(2):73-80. doi: 10.1080/09537100400005634. Platelets. 2005. PMID: 15823862

6

PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.

Smith SM, Judge HM, Peters G, Armstrong M, Dupont A, Gaussem P, Storey RF. Smith SM, et al. Among authors: storey rf. Platelets. 2005 Sep;16(6):340-5. doi: 10.1080/00207230500120294. Platelets. 2005. PMID: 16194864

7

Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.

Judge HM, Buckland RJ, Holgate CE, Storey RF. Judge HM, et al. Among authors: storey rf. Platelets. 2005 Nov;16(7):398-407. doi: 10.1080/09537100500163226. Platelets. 2005. PMID: 16236601

8

Utility of a whole blood single platelet counting assay to monitor the effects of tirofiban in patients with acute coronary syndromes scheduled for coronary intervention.

Siotia A, Buckland R, Judge HM, Sastry P, Storey RF. Siotia A, et al. Among authors: storey rf. Thromb Haemost. 2006 Jun;95(6):997-1002. doi: 10.1160/TH05-08-0544. Thromb Haemost. 2006. PMID: 16732379 Clinical Trial.

9

Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy.

Smith SM, Judge HM, Peters G, Armstrong M, Fontana P, Gaussem P, Daly ME, Storey RF. Smith SM, et al. Among authors: storey rf. Platelets. 2006 Jun;17(4):250-8. doi: 10.1080/09537100500475844. Platelets. 2006. PMID: 16769602 Clinical Trial.

10

Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.

Storey RF, Husted S, Harrington RA, Heptinstall S, Wilcox RG, Peters G, Wickens M, Emanuelsson H, Gurbel P, Grande P, Cannon CP. Storey RF, et al. J Am Coll Cardiol. 2007 Nov 6;50(19):1852-6. doi: 10.1016/j.jacc.2007.07.058. Epub 2007 Oct 23. J Am Coll Cardiol. 2007. PMID: 17980251 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

400 results

Search Page